YARROW BIOSCIENCE, INC. Net Income (Loss) Available to Common Stockholders, Basic
YARROW BIOSCIENCE, INC. (YARW) reported Net Income (Loss) Available to Common Stockholders, Basic of -$73.70 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-12-31 was -$21.50M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-09-30 was -$16.86M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-06-30 was -$16.48M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-03-31 was -$18.87M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for fiscal 2019 was -$73.70M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for fiscal 2018 was -$51.45M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for fiscal 2017 was -$29.08M.
- YARROW BIOSCIENCE, INC. net income (loss) available to common stockholders, basic for fiscal 2016 was -$14.07M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$21.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$38.35M derived: sum of 2 quarters · filed 2020-03-03 | -$54.83M derived: sum of 3 quarters · filed 2020-03-03 | -$73.70M 10-K · filed 2020-03-03 |
| 2019-09-30 | -$16.86M 10-Q · filed 2019-10-31 | -$33.33M derived: sum of 2 quarters · filed 2019-10-31 | -$52.20M 10-Q · filed 2019-10-31 | -$69.80M derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-06-30 | -$16.48M 10-Q · filed 2019-08-01 | -$35.35M 10-Q · filed 2019-08-01 | -$52.94M derived: sum of 3 quarters · filed 2020-03-03 | -$65.79M derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-03-31 | -$18.87M 10-Q · filed 2019-05-02 | -$36.47M derived: sum of 2 quarters · filed 2020-03-03 | -$49.31M derived: sum of 3 quarters · filed 2020-03-03 | -$57.66M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-12-31 | -$17.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$30.44M derived: sum of 2 quarters · filed 2020-03-03 | -$38.79M derived: sum of 3 quarters · filed 2020-03-03 | -$51.45M 10-K · filed 2020-03-03 |
| 2018-09-30 | -$12.85M 10-Q · filed 2019-10-31 | -$21.19M derived: sum of 2 quarters · filed 2019-10-31 | -$33.85M 10-Q · filed 2019-10-31 | -$43.13M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$8.35M 10-Q · filed 2019-08-01 | -$21.00M 10-Q · filed 2019-08-01 | -$30.28M derived: sum of 3 quarters · filed 2020-03-03 | -$38.45M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | -$12.66M 10-Q · filed 2019-05-02 | -$21.93M derived: sum of 2 quarters · filed 2020-03-03 | -$30.11M derived: sum of 3 quarters · filed 2020-03-03 | -$36.26M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | -$9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$17.45M derived: sum of 2 quarters · filed 2020-03-03 | -$23.60M derived: sum of 3 quarters · filed 2020-03-03 | -$29.08M 10-K · filed 2020-03-03 |
| 2017-09-30 | -$8.17M 10-Q · filed 2018-11-07 | -$14.32M derived: sum of 2 quarters · filed 2018-11-07 | -$19.80M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$6.15M 10-Q · filed 2018-08-01 | -$11.63M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | -$5.47M 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | -$14.07M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | -$4.61M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |